Measuring adherence to antiretroviral medications in clinical trials.
about
HIV Treatment Adherence, Drug Resistance, Virologic Failure: Evolving ConceptsLack of association between retrospectively collected pharmacy refill data and electronic drug monitoring of antiretroviral adherence.Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management.Postpartum discontinuation of antiretroviral therapy and risk of maternal AIDS-defining events, non-AIDS-defining events, and mortality among a cohort of HIV-1-infected women in the United States.Guide to designing, conducting, publishing and communicating results of clinical studies involving probiotic applications in human participants.Adherence evaluation of endocrine treatment in breast cancer: methodological aspects.Monitoring Antiretroviral Therapy in HIV-Infected Children in Resource-Limited Countries: A Tale of Two EpidemicsCaregivers' Attitudes towards HIV Testing and Disclosure of HIV Status to At-Risk Children in Rural Uganda.Compliance with anthelmintic treatment in the neglected tropical diseases control programmes: a systematic review.Reactions, beliefs and concerns associated with providing hair specimens for medical research among a South African sample: a qualitative approachRelationship between Adherence to Oral Antibiotics and Postdischarge Clinical Outcomes among Patients Hospitalized with Staphylococcus aureus Skin InfectionsAn evaluation of methods to improve the reporting of adherence in a placebo gel trial in Andhra Pradesh, India.Adherence to antiretroviral drug therapy in adult patients who are HIV-positive in Northwest Ethiopia: a study protocol.Assessing antiretroviral adherence via electronic drug monitoring and self-report: an examination of key methodological issuesSofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1-Infected Individuals: SWIFT-C.Which adherence measure - self-report, clinician recorded or pharmacy refill - is best able to predict detectable viral load in a public ART programme without routine plasma viral load monitoring?Adherence to antiretroviral therapy and its impact on clinical outcome in HIV-infected patients.High adherence and concordance within a clinical trial of antihypertensives.Sleep disturbance and depression as barriers to adherence.Factors influencing adherence to ART: new insights from a center providing free ART under the national program in Delhi, India.A randomized trial of directly administered antiretroviral therapy and adherence case management intervention.Assessing baseline religious practices and beliefs to predict adherence to highly active antiretroviral therapy among HIV-infected persons.Evaluation of compliance to congenital Chagas disease treatment: results of a randomised trial in BoliviaGuidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel
P2860
Q22241321-6B6A4AB8-9A08-4986-B41D-DD87CEF2139DQ33393729-64226683-399C-46F8-A4B6-3ED7BF9D5C7BQ33851716-CDDADC25-BC2C-4108-9012-55A2ABD4E86CQ33875036-AF07931D-49F2-41AF-A604-17BEB8A53289Q34165056-F33CEB49-59EB-496E-8942-EE06B02551ACQ34445764-96817235-5C42-4738-A43B-169154452A23Q34734797-496897D0-C302-4388-A381-1AFA801360ADQ35924864-8EB783F3-28A3-40D2-97F7-8DAE7D887702Q36508829-6D6A4109-4988-4820-89BE-82F95E1B4E9BQ36808036-70815C85-A387-4AFB-8BA1-5883FF437295Q36887908-EC1E0D30-A781-45C1-8DA1-799F9CEAFE08Q36906506-EF8DC358-F4B1-4B69-B11B-B590F4EFD615Q37275804-4E01C2B8-4DA3-4899-B94E-E7AD4E562AE1Q37395005-FE9C2EFE-E505-4B88-A47A-6595A9AA93A1Q40280603-AFF1BE2A-50C1-4FEF-A048-AAE957B73DACQ40697700-5C8E5C4D-23A6-4BC1-B3F0-B5A2EEA4BD20Q43260037-09D9E885-6E3F-48F5-AC56-886689F552A5Q44157624-80754E24-B1AB-4AB5-BB0C-6D1455564FF8Q44526140-56922808-C2ED-4C90-9292-360F315628B2Q44804873-8BEA8E94-6138-4DFE-8FF7-D62D2C33E560Q46151796-7FE7C017-81A5-426A-A6C9-EBDC6217C7E7Q46665882-19E20D15-14AD-4F6D-8E97-E18E596DF763Q56829258-0179B389-D439-4EFC-95D5-42094F15E90BQ56973152-D6967209-3AA1-426B-A895-253F50D2EB8C
P2860
Measuring adherence to antiretroviral medications in clinical trials.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Measuring adherence to antiretroviral medications in clinical trials.
@ast
Measuring adherence to antiretroviral medications in clinical trials.
@en
Measuring adherence to antiretroviral medications in clinical trials.
@nl
type
label
Measuring adherence to antiretroviral medications in clinical trials.
@ast
Measuring adherence to antiretroviral medications in clinical trials.
@en
Measuring adherence to antiretroviral medications in clinical trials.
@nl
prefLabel
Measuring adherence to antiretroviral medications in clinical trials.
@ast
Measuring adherence to antiretroviral medications in clinical trials.
@en
Measuring adherence to antiretroviral medications in clinical trials.
@nl
P1433
P1476
Measuring adherence to antiretroviral medications in clinical trials.
@en
P2093
P356
10.1310/ENXW-95PB-5NGW-1F40
P577
2000-07-01T00:00:00Z